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Abstract A novel alkaline phosphatase, designated PiALP, has
been purified and characterized from Prevotella intermedia
ATCC 25611, an anaerobe implicated in progressive periodontal
disease. The enzyme was a homodimer of apparently identical
subunits of Mr 54 kDa. Thiol-reducing agents completely
inhibited the purified enzyme. The enzyme was highly stable
even at 80‡C. It exhibited substantial activity against tyrosine-
phosphate-containing Raytide. The phosphatase activity was
sensitive to orthovanadate and Zn2+ but highly resistant to
okadaic acid. The amino acid sequence of peptides derived from
PiALP showed a high degree of identity (65%) with alkaline
phosphatases from Zymomonas mobilis and Synechococcus. The
present results imply that PiALP might represent a new family of
alkaline phosphotyrosyl phosphatases which has not been
described previously.
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1. Introduction
Prevotella intermedia, an anaerobic, Gram-negative, rod-
shaped bacterium, is isolated from lesions of rapidly aggres-
sive periodontitis and is strongly implicated as a periodontal
pathogen [1]. While the detailed mechanism of pathogenesis of
this organism remains unknown, it produces a variety of po-
tential virulence factors, including high alkaline phosphatase
(ALPase) activity [2,3]. However, only limited information is
currently available regarding the phosphatase activities of the
periodontopathic bacteria. While studying the properties of
the ALPase from P. intermedia, we found that the puri¢ed
enzyme exhibited substantial activities against O-phospho-L-
tyrosine, a compound that acts as substrate for phospho-
tyrosyl phosphatase (PTPase). In the present study, we re-
port the puri¢cation and characterization of a novel ALPase
containing PTPase activity from the bacterium P. inter-
media. In addition, the internal amino acids of the protein
sequences were obtained and compared with the other phos-
phatases.
2. Materials and methods
2.1. Bacterial strain and growth conditions
P. intermedia ATCC 25611 was kindly provided by T. Koga,
Kyushu University, Fukuoka, Japan. P. intermedia ATCC 25611
was grown anaerobically [5% (v/v) CO2, 10% (v/v) H2, 85% (v/v)
N2] at 37‡C for 2 days in brain heart infusion broth (Difco) supple-
mented with yeast extract (0.5%), hemin (5 Wg/ml) and menadione
(0.5 Wg/ml).
2.2. Enzyme assay
Standard phosphatase reactions were carried out in 50 mM Tris-
HCl, pH 7.8/50 mM NaCl/5% glycerol at 37‡C for 30 min. The fol-
lowing substrates were used. (i) pNPP: 1 ml reaction mixtures con-
tained 10 Wmol of pNPP; absorption at 420 nm was measured. One
unit of phosphatase activity corresponded to 1 Wmol of substrate
hydrolyzed per min at 37‡C. (ii) Raytide (Oncogene Science):
40 nmol of Raytide was phosphorylated by p60cÿsrc (Oncogene Sci-
ence) in the presence of [Q-32P]ATP as described by Barik [4]. Unin-
corporated ATP was then removed by passing the reaction mixture
through a Sephadex G-50 quick-spin column. (iii) Phosphorylase ki-
nase: 5 Wg of phosphorylase kinase (Sigma) was phosphorylated in
vitro by cAMP-dependent protein kinase (PKA) and [Q-32P]ATP as
described by Barik [4]. 32P-labeled Raytide and phosphorylase kinase
were analyzed by denaturing 40% and 20% polyacrylamide gels, re-
spectively, essentially as described [5]. The radioactivities were quan-
titated using densitometric scanning apparatus, Bio-Image Analyzer
BAS 2000 (Fuji ¢lm) [6].
The optimal pH was determined using 0.1 M acetate bu¡er (pH
5.0^6.5), 0.1 M Tris-HCl bu¡er (pH 6.5^8.5), and 0.1 M glycine-
NaOH bu¡er (pH 8.5^10.0).
2.3. Puri¢cation
All procedures were carried out at 4‡C. Bacterial cells (20 g) were
harvested from 8 l culture of P. intermedia ATCC 25611 by centrifu-
gation at 10 000Ug for 20 min. The cells were washed twice with 0.1 M
Tris-HCl bu¡er (pH 7.5) containing 0.15 M NaCl (TBS bu¡er), sus-
pended in 50 mM Tris-HCl (pH 7.5), and broken by sonic disruption
using six 1-min pulses of a sonic disruptor. The resulting sonicate was
stirred in the same bu¡er containing 1% Triton X-114 for 3 h at 4‡C,
and then was centrifuged at 100 000Ug for 40 min. The supernatant
fraction was collected as the crude enzyme extract and applied to a
DEAE Bio-Gel (Bio-Rad) column (6U20 cm) that had been equili-
brated with 50 mM Tris-HCl bu¡er (pH 8.4). The column was washed
with the equilibration bu¡er until no protein was detected in the
e¥uent by measurement of A280, and then developed with a linear
gradient of NaCl (0^0.5 M) in the bu¡er. The active fractions were
pooled and concentrated by ¢ltration through a Centricon-30 ultra-
¢ltration device (Amicon). The concentrated solution was applied to a
CM Bio-Gel (Bio-Rad) column (1U30 cm) equilibrated with 50 mM
Tris-HCl bu¡er (pH 7.5). The enzyme was eluted with a linear gra-
dient of NaCl (0^0.5 M) in the same bu¡er. The active fractions were
pooled and dialyzed against 100 mM potassium phosphate bu¡er (pH
7.5) containing 100 mM NaCl. The dialyzed enzyme solution was
applied to a column of Sephacryl S-300 (Pharmacia) (1U90 cm) equil-
ibrated with the same bu¡er as for the dialysis. The active fractions
were pooled and concentrated as described above. The concentrated
enzyme solution was applied to a column of HiTrap Chelating (Phar-
macia) (bed volume 1 ml) equilibrated with 50 mM potassium phos-
phate bu¡er (pH 7.2) containing 0.5 M NaCl connected to a FPLC
system (Pharmacia). The enzyme was eluted with the equilibration
bu¡er containing 1 M glycine. This procedure was repeated four times
and the pooled active fractions were concentrated 5-fold with Centri-
FEBS 20279 29-5-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 5 1 4 - 6
*Corresponding author. Fax: (81) (93) 591-7736.
E-mail: ansai@kyu-dent.ac.jp
FEBS 20279 FEBS Letters 428 (1998) 157^160
con-30. The concentrated enzyme solution was subjected to FPLC
using Superdex 200HR 10/30 pre-equilibrated with 200 mM Tris-
HCl (pH 7.5), which was also used for determining the molecular
mass of PiALP. For molecular weight standards, the MW-Marker
kit was used (Oriental Yeast). The puri¢ed enzyme was frozen and
stored at 380‡C.
2.4. Peptide microsequencing
Initial attempts to sequence PiALP were unsuccessful and indicated
that the N-terminal region of the protein was blocked. The puri¢ed
protein was thus digested with Staphylococcus aureus V8 protease.
The peptides generated were separated on SDS-PAGE on 20% gels
and electrophoretically transferred to Immobilon-P. Microsequencing
(Takara Shuzo) was performed on an automatic gas phase sequencer,
HP G1005A (Hewlett-Packard, CA, USA).
2.5. Thermostability studies
The enzyme was incubated at various temperatures in 50 mM Tris-
HCl (pH 9.0) for di¡erent periods of time. Thermal inactivation was
stopped by cooling the aliquots on ice, and then the residual phos-
phatase activity was measured at 37‡C.
2.6. Other methods
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed to determine the molecular mass of the sub-
units by the method of Laemmli [7]. Molecular weight markers for
SDS-PAGE were from Bio-Rad. Protein concentrations were rou-
tinely estimated according to Bradford [8] with bovine serum albumin
as the standard.
3. Results
3.1. Puri¢cation of PiALP
The puri¢cation of PiALP from Triton X-114 extracts is
summarized in Table 1. The PiALP was puri¢ed 109-fold
with a ¢nal speci¢c activity of 356.3 U/mg, and the overall
yield of the activity was 4.1%. The most notable property
observed in the course of puri¢cation was that the enzyme
bound on both anion- and cation-exchange chromatographic
matrices. This enabled us to successfully separate the enzyme
from other P. intermedia proteins.
The molecular mass of native enzyme from P. intermedia
was estimated by gel ¢ltration to be V108 kDa. On SDS-
PAGE, the puri¢ed enzyme revealed a single band with a
molecular mass of V54 kDa (Fig. 1). These results suggested
that the enzyme was a homodimer of identical 54-kDa sub-
units.
3.2. Temperature and pH optima of PiALP
The optimal temperature and pH for PiALP were deter-
mined in vitro by using pNPP as a substrate; essentially sim-
ilar results were obtained by using a phosphorylated peptide
such as Raytide (data not shown). The puri¢ed enzyme had
the highest activity at around 65‡C for pNPP as substrate. It
was found to be extremely stable to heating. No loss of ac-
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Table 1
Puri¢cation of ALPase from P. intermedia ATCC 25611
Preparation Total activity Total protein Speci¢c activity Yield Puri¢cation
(U)a (mg) (U/mg) (%) (fold)
Triton X-114 extract 701.6 214.15 3.28 100 1
DEAE Bio-Gel agarose 197.5 17.60 11.22 28.1 3.4
CM Bio-Gel agarose 79.6 2.40 33.17 11.3 10.1
Sephacryl S-300 46.4 0.58 80.00 6.6 24.4
HiTrap chelating 35.3 0.15 235.30 5.0 71.7
Superdex 200Hr 10/30 28.5 0.08 356.25 4.1 108.6
aPhosphatase activity was measured with pNPP as substrate.
Fig. 1. Puri¢cation of PiALP. SDS-PAGE analysis was performed
on 14% gels. The gel was stained with Coomassie brilliant blue.
Lane 1 contains the puri¢ed PiALP (3 Wg), and lane M contains
molecular weight markers. The positions and molecular weights of
standard proteins are indicated in the left lane.
Fig. 2. Thermostability of PiALP. Enzyme solution at a concentra-
tion of 10 Wg/ml was incubated at various temperatures and cooled
on ice. The residual activity was measured at 37‡C with an enzyme
concentration of 1 Wg/ml.
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tivity was observed after 10 min incubation at 80‡C. The time
required for 50% loss of activity was about 90 min at 55‡C
(Fig. 2). The optimum pH value for the activity was approx-
imately 8.4.
3.3. Inactivation of PiALP by DTT
PiALP was quite sensitive to inhibition by thiol-reducing
agents such as DTT and 2-mercaptoethanol (Table 2). How-
ever, this inactivation was reversible, since the activity of the
DTT-treated PiALP was almost completely recovered after
removal of the DTT by dialysis.
3.4. E¡ect of inhibitors on PiALP activity
To characterize PiALP further, the e¡ect of inhibitors on
the activity of the enzyme was investigated. As shown in Ta-
ble 3, sodium orthovanadate, sodium molybdate and N-ethyl-
maleimide, which are known inhibitors of PTPases, were also
found to inhibit the activity of PiALP. On the other hand, the
activity was not inhibited by okadaic acid, which is known to
be a speci¢c inhibitor of serine/threonine protein phospha-
tases. Other compounds, including EDTA and Zn2, also in-
hibited the activity.
3.5. Substrate speci¢city of PiALP
As shown in Fig. 3, Raytide, a synthetic peptide containing
tyrosine as the only phosphorylated residue, was found to be
an e⁄cient substrate for PiALP. Angiotensin II, phosphoryl-
ated tyrosine residue by p60cÿsrc, was dephosphorylated by
PiALP (data not shown). However, it exhibited no detectable
phosphatase activity toward phosphorylase kinase.
3.6. Determination of the internal amino acid sequence of the
puri¢ed PiALP
The N-terminal sequence of the protein could not be se-
quenced, since its amino-terminus appeared to be blocked.
Another sample of electrophoretically puri¢ed PiALP was
subjected to partial digestion with S. aureus V8 protease.
The resulting peptides were separated by SDS-PAGE, electro-
blotted onto PVDF membranes, and visualized with Coomas-
sie blue. Portions of the membranes containing the most vis-
ually prominent bands were excised and subjected to 20 cycles
of automated gas-phase Edman sequence analysis. As shown
in Table 4, a distinct sequence was obtained, Thr-Asp-Met-
Leu-Ala-Val-Ser-Val-Ser-Ser-Thr-Asp-Ala-Ile-Gly-His-Lys-
Tyr-Gly-Thr. The amino acid sequence had 65% identity with
two ALPases, PhoD from Zymomonas mobilis [9] and PhoV
from Synechococcus [10]. Interestingly, a sequence homolo-
gous to the putative phosphorylation site [10], Leu-Ala-Val-
Ser-Leu-Ser-Ser-Thr-Asp-Ala-Val, was found.
4. Discussion
In the present study, a novel alkaline phosphatase, PiALP,
was puri¢ed to homogeneity from P. intermedia and we dis-
covered that it contained PTPase activity. Phosphatase activ-
ities have been observed in several periodontopathogenic bac-
teria, including P. intermedia. However, limited information is
known about these phosphatases. Only two phosphatases
from oral bacteria have been reported [11,12]. Concerning
ALPases from oral bacteria, only one ALPase, from Porphy-
romonas gingivalis (PgALP), has been puri¢ed and character-
ized so far. PgALP has been shown to be a homodimer of
identical subunits of Mr 61 kDa and have phosphoseryl phos-
phatase activity [12]. The result of SDS-PAGE (Fig. 1) and
HPLC analysis of PiALP showed that it was a homodimer
having a molecular weight of about 54 kDa. The thermo-
stability of PiALP was evidenced by its high temperature op-
timum of 65‡C and its ability to retain 50% activity even after
15 min exposure at 80‡C (Fig. 2). The extreme thermal stabil-
ity of an enzyme from a human oral bacterium is without
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Table 2
E¡ect of thiol-reducing agents on the activity of PiALP
Compound Concentration (mM) % of activity
None 100
Dithiothreitol 1 10
10 0
2-Mercaptoethanol 1 71
10 5
pNPP (10 mM) was used as substrate under standard assay conditions
as described.
Table 3
E¡ect of various chemicals on the activity of PiALP
Chemical Concentration % of activity
None 100
Sodium molybdate 1 mM 31
Sodium orthovanadate 1 mM 1
N-Ethylmaleimide 5 mM 66
Okadaic acid 1 WM 113
ZnCl2 2 mM 6
EDTA 5 mM 0
pNPP (10 mM) was used as substrate under standard assay conditions
as described.
Fig. 3. Substrate speci¢city of PiALP. Puri¢ed PiALP (1 Wl, con-
taining 0.5 Wg of protein) was assayed for activity toward a variety
of phosphoprotein substrates. Standard assay conditions were em-
ployed as described in Section 2. At various times, 5 Wl portions of
the reaction mixture were taken out and analyzed by SDS-PAGE,
followed by direct autoradiography and densitometric scanning of
the autoradiograph. Shown are the percentages of phosphate re-
maining versus time of incubation for Raytide (b) and phosphoryl-
ase kinase (F) as substrates.
T. Ansai et al./FEBS Letters 428 (1998) 157^160 159
precedence and de¢es explanation at present. It is tempting to
speculate that an ancestral relatedness between P. intermedia
and the oldest phylogenetic kingdom in nature, such as the
hyperthermophilic archaebacteria, exists, raising fundamental
questions about the origin and the role of tyrosine phospho-
rylation.
The 20 internal amino acid sequences of PiALP were com-
pared with all the protein sequences in the SwissProt database
and BLAST program. A signi¢cant high sequence similarity
was found between PiALP and the ALPases of Z. mobilis
(PhoD) and the cyanobacterium Synechococcus (PhoV). The
PiALP contained a putative phosphorylation site (LAV-
SLSSTD(Y/A)V) that is conserved between PhoD and
PhoV, although the involvement of this site in regulation of
activity remains speculative [9,10]. These results strongly in-
dicated that the PiALP would belong to the same family with
PhoD from Z. mobilis and PhoV from Synechococcus. On the
other hand, in previous studies [9,10], PTPase activities in
these two ALPases were not investigated. Unfortunately, no
information is available about PTPase activities of PhoD and
PhoV at present. Escherichia coli ALPase also has PTPase
activity [13], but it did not appear to show signi¢cant homol-
ogy with PiALP, PhoD and PhoV. Furthermore, from the
standpoint of its substrate speci¢city for phosphorylase kinase
and the sensitivity to dithiothreitol and divalent ion for activ-
ity, PiALP would be distinct from E. coli ALPase [14]. On the
other hand, when reviewing the complete sequences of PhoD
and PhoV, we were not able to ¢nd the highly conservative
motif HCXAGXGR (both Cys and Arg are essential for ac-
tivity) in the active domain of PTPases [15]. PiALP also
shared no overall sequence with the SA (small, acidic)
PTPases, which are the prokaryotic PTPases without this mo-
tif [16]. However, PiALP was inhibited by sodium orthovana-
date, sodium molybdate and Zn2, which are known inhibi-
tors of PTPases [17]. Furthermore, it did exhibit substantial
activity against tyrosine-phosphates, since it could dephos-
phorylate Raytide (a gastrin derivative) as well as angiotensin
II. These results suggest that this ALPase group (i.e. PhoD,
PhoV and PiALP) might constitute a novel family of alkaline
PTPases signi¢cantly di¡erent from other known PTPases.
The dissociation of the PiALP dimer by thiol-reducing
agents and simultaneous loss of enzymatic activity strongly
suggests that the two subunits are jointed by disul¢de bond(s),
and that the dimer is the active form. All PTPs reported to
date contain a signature sequence, HCXAGXGR, at their
active site. Catalysis has been shown to proceed through the
formation of a covalent phospho-thio intermediate involving
the Cys residue of the signature sequence [18]. The fact that
PiALP not only does not require thiol-reducing agents for
activity, but these agents actually inhibit its activity, suggests
that the mechanism of PiALP action must be di¡erent from
that of the known PTPases.
In conclusion, we have puri¢ed a novel prokaryotic ALPase
containing a PTPase activity. Cloning and complete sequenc-
ing of the PiALP gene and further studies of its structure and
function will help clarify the mechanism behind its unique
biochemical properties as described here.
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Table 4
Comparison of the amino acid sequences of peptides derived from
PiALP with other phosphatases
Amino acids which are identical in PiALP and one or both of SphoV
and ZmphoD are shown in solid-line boxes, with conservative amino
acid changes in dashed-lined boxes. SphoV: PhoV of Synechococcus ;
ZmphoD: PhoD of Z. mobilis.
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